Lipase-catalyzed interesterification of soybean oil with an ω-3 polyunsaturated fatty acid concentrate prepared from sardine oil

被引:0
作者
Masamichi Akimoto
Maki Izawa
Kazumi Hoshino
Ken-Ichi Abe
Hiromi Takahashi
机构
[1] Niigata Institute of Technology,Department of Applied Chemistry and Biotechnology
来源
Applied Biochemistry and Biotechnology | 2003年 / 104卷
关键词
Interesterification; acidolysis; kinetics; soybean oil; eicosapentaenoic acid; docosa hexaenoic acid; lipase; Lipozyme IM; sardine oil;
D O I
暂无
中图分类号
学科分类号
摘要
Toreduce the content of limoleoyl moiety in soybean oil, soybean oil that contains 53.0% linoleoyl moiety as molar acyl moiety composition was interesterified with an ω-3 polyunsaturated fatty acid (PUFA) concentrate (240 mol% elcosapentaenoic acid [EPA], 40.4 mol% docosahexaenoic acid [DHA]) prepared from sardine oil, using an immobilized sn-1,3-specific lipase from Rhizomucor michei (Lipozyme IM). The reaction was carried out in a batch reactor at 37°C under the following conditions: 500 μmol of soybean oil, molar ratio of ω-3 PUFA concentrate to soybean oil=1.0–6.0, 5.0 mL of heptane, and 30 batch interesterification units of enzyme. After the reaction time of 72h, modified soybean oil, which contains 34.9% linoleoyl, 10.1% eicosapentaenoyl, and 14.2% docosahexaenoyl moieties, was produced at the molar reactant ratio of 6.0. In this oil, the total ω-3 acyl moiety composition reached 34.1%; the molar ratio of ω-3 to ω-6 acyl moieties was enhanced by five times compared with soybean oil. Compared with palmitic acid, DHA was kinetically six times less reactive, although the EPA was by 16% more reactive.
引用
收藏
页码:105 / 118
页数:13
相关论文
共 138 条
[1]  
Karmali R. A.(1984)undefined J. Natl. Cancer Inst. 73 457-461
[2]  
Marsh J.(1985)undefined J. Natl. Cancer Inst. 74 1145-1151
[3]  
Fuchs C.(1986)undefined J. Natl. Cancer Inst. 76 1223-1231
[4]  
Jurkowski J. J.(1986)undefined Lipids 21 285-288
[5]  
Cave W. T.(1989)undefined J. Clin. Exp. Med. (Igaku no Ayumi) 150 233-234
[6]  
Garor H.(1989)undefined Nutr. Res. 9 383-393
[7]  
Abraham S.(1991)undefined Lipids 26 866-870
[8]  
Braden L. M.(1981)undefined Cancer Res. 41 1460-1465
[9]  
Carroll K. K.(1983)undefined Cancer Res. 43 1079-1083
[10]  
Yonekura I.(1985)undefined N. Engl. J. Med. 312 1205-1209